Purchases and Sales Made in Q2 2024 in Immunome Inc. (IMNM)
This table provides information about the institutional ownership of Immunome Inc. (IMNM) during Q2 2024. The information is specifically focused on institutions that hold shares of Immunome Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 13, 2024
Q2 2024
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-148K- 44.46% |
$1.7M - $3.26M
|
184K
$1.58M
|
|
|
Aug 14, 2024
Q2 2024
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-225K- 10.0% |
$2.59M - $4.96M
|
2.02M
$17.3M
|
|
|
Aug 13, 2024
Q2 2024
|
Atika Capital Management LLC
New York, NY |
SELL
|
- |
-241K- 76.51% |
$2.78M - $5.33M
|
74K
$633K
|
|
|
Aug 15, 2024
Q2 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-290K- 90.7% |
$3.34M - $6.41M
|
29.7K
$254K
|
|
|
Aug 14, 2024
Q2 2024
|
Woodline Partners LP
San Francisco, CA |
SELL
|
- |
-395K- 29.98% |
$4.56M - $8.74M
|
923K
$7.9M
|
|
|
Aug 13, 2024
Q2 2024
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-599K- 95.85% |
$6.91M - $13.2M
|
25.9K
$222K
|
|
|
Aug 14, 2024
Q2 2024
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-1.26M- 76.55% |
$14.5M - $27.8M
|
385K
$3.3M
|